News
Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...
11d
News-Medical.Net on MSNOveruse injuries spark lasting pain and mood changes through inflammation, rat study findsRepetitive reaching tasks in mature female rats triggered persistent pain-like and sickness behaviors linked to a surge in IL ...
A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.
EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare gene ...
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...
Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.
No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...
Bowl of Quick Cook on MSN13d
Beyond the Physical: Unraveling the Mystery of Chronic Nausea When Simple Answers FailFeeling constantly sick to one’s stomach is truly awful. It deprives individuals of simple pleasures, such as enjoying food ...
2d
Asheville Watchdog on MSN“Dreadful” and “hopelessly behind”: FEMA flood maps reveal their flaws in a time of warming and extreme stormsIf Steve Dunning’s Okie Dokies Smokehouse in Swannanoa appeared on the Federal Emergency Management Agency’s flood maps, his ...
NAION is the second most frequent cause of vision loss due to optic nerve damage, with advanced age and long-standing type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results